Search – Page 197 – Indianapolis Business Journal

Home » Search

Articles

Expectations high as Economic Club opens season: Group sees turnaround in sponsorships, attendance

September 15, 2008

Organizers of the Economic Club of Indiana believe they’ll hit a home run when their first speaker of the season, Eli Lilly and Co.’s new CEO, John Lechleiter, steps to the podium Sept. 24. “I believe John Lechleiter will blow the socks off the place,” predicted Steve Walker, who serves as club president and also is CEO of WalkerInformation. Just a few years ago, club organizers weren’t in a position to be so upbeat. Early this decade, the club witnessed…

Lilly Endowment crawls toward diversification goal: Bear market, low Lilly stock price slow selloff

September 15, 2008

Lilly Endowment Inc. is still on its journey to sell off $2 billion of its Eli Lilly and Co. shares. But after a slow start and a few stops for rest, it may take a little longer to get there than originally thought. The endowment, the single largest holder of Lilly stock, announced its plan to diversify its holdings back in July 2006. For nearly 70 years, the not-for-profit held its wealth almost exclusively in the pharmaceutical company’s stock. So…

Commentary: Indiana law chases away talent

September 8, 2008

The Wellness Community of Central Indiana was established in 1995 as a not-for-profit organization to provide free support, education and hope to individuals and families affected by cancer. At The Wellness Community, cancer patients can share experiences and lend one another encouragement informally or through programs facilitated by professional counselors. The Wellness Community also provides a haven to grieve together in those instances when cancer is the ultimate victor. Today, the folks at The Wellness Community are grieving over a…

ON THE RECORD:

September 8, 2008

O N T H E R E C O R D First Merchants Corp. of Muncie announced Sept. 3 that it has agreed to buy Lincoln Bancorp of Plainfield for about $75 million. The acquisition expands First Merchants’ presence in the Indianapolis area from the northern suburbs into other fast-growing suburbs on the west and south sides. Announcement of the deal sparked a 37-percent runup in the value of Lincoln shares. Elanco, the animal-health division of Eli Lilly and Co.,…

Zyprexa class action given green light

September 5, 2008

Enough evidence of fraud by Eli Lilly and Co. in its marketing of Zyprexa exists to go ahead with a jury trial, a judge in New York has ruled. Plaintiffs in the case claim Lilly urged physicians to prescribe the schizophrenia and bipolar disorder drug for uses not approved by the federal government. Insurance companies, […]

Lilly continues to build case for prasugrel

September 3, 2008

Eli Lilly and Co. continued to press its case for regulatory approval of its blood thinner prasugrel today by releasing two more studies offering new analysis of prasugrel’s clinical trial data. The release comes weeks before the U.S. Food and Drug Administration is scheduled to rule on whether the drug should be allowed onto the […]

Elanco home base moving to life sciences park

September 2, 2008

Elanco, the animal health division of Eli Lilly and Co., will move into a new 135,000-square-foot headquarters in Greenfield by the spring of 2010, the company announced today. Elanco’s new offices will go up on the northwest corner of State Road 9 and I-70, where Indianapolis developer Browning Investments Inc. is building a 52-acre life […]

Cymbalta helps lower-back pain, Lilly says

August 25, 2008

Eli Lilly and Co. said its depression drug Cymbalta showed some effectiveness against chronic low back pain, according to data presented today in Spain. The study gives Lilly evidence to perhaps get Cymbalta approved to treat yet another medical condition. The drug already has approval to treat depression, generalized anxiety disorder, diabetic nerve pain and […]

Citizens’ new name is a gas-in a way: Parent company of local utility adds ‘energy’ to its moniker to reflect diversity of operations

August 25, 2008

Citizens Gas & Coke Utility on Aug. 25 will announce a new name and logo that reflect the diversification of its energy businesses and the closure last year of its 98-year-old foundry coke plant. Citizens Energy Group will be the name of the parent, a utility founded 120 years ago. Two units-Citizens Gas and Citizens Thermal-will retain their names. But a third, Citizens By-Products, will be renamed Citizens Resources. “We’re entering a new era,” said Citizens President and CEO Carey…

Cautious contractors warm to Lilly-Covance deal: Drugmaker works to assuage fears of some local researchers worried they might lose lucrative work

August 25, 2008

When Eli Lilly and Co. announced Aug. 6 that it would more than double the amount of research and development work it outsources to Covance Inc., Dr. Alfonso Alanis got nervous. The CEO of contract researcher Anaclim LLC worried that more work for Covance would mean less work for local firms that provide drug development services to Lilly. Executives at other local firms, who asked not to be named because of confidentiality agreements with Lilly, also have fretted that their…

Lilly’s Cymbalta approved by European panel

August 22, 2008

The European Commission has approved Cymbalta, the anxiety drug developed by Eli Lilly and Co. The thumbs-up came from the commission’s European Medicine Agency Committee for Medicinal Products for Human Use, the Indianapolis company said today. The approval opens markets in 27 European Union nations as well as Iceland, Liechtenstein and Norway. Lilly estimates nine […]

Lilly buys dairy hormone unit for $300M

August 20, 2008

Elanco, a division of Eli Lilly and Co., will spend $300 million and an undisclosed “contingent consideration” to buy all rights to a popular dairy cow hormone and its sales and manufacturing operations from St. Louis-based Monsanto Co. Elanco has been selling the supplement, called Posilac, outside the United States for a decade. Now Elanco […]

Lafayette officials hoping for best on Lilly plant

August 18, 2008

Lafayette-area leaders anticipate meeting soon with Eli Lilly and Co. officials to try to play a role in the Indianapolis-based drug giant’s plans for the 54-year-old Tippecanoe Laboratories, according to The Journal & Courier of Lafayette. Lilly said July 30 that an announcement on the future of the plant would be forthcoming within a year. […]

Huguenard a billion-dollar broker: Senior vice president at Colliers one of the nation’s top deal-makers

August 18, 2008

John E. Huguenard is on a roll. He’s got $1 billion in active industrial listings and is on track to top his $700 million deal volume from last year. The low-key super-broker for the local office of commercial real estate powerhouse Colliers Turley Martin Tucker has closed 17 deals worth a total of $250 million already this year. And that’s no fluke: Huguenard, 45, has sold or leased more than 100 million square feet of industrial property in more than…

Firm brings big-name help to small not-for-profits: Consultant will offer tiered Web-based advice to help keep its fees affordable

August 18, 2008

Some heavy hitters in the local not-forprofit consulting world have formed Achieve LLC, a company that will use the Internet to make high-end advice available to small and midsize charities. Its goal is to give organizations experiencing growing pains access to expert advice they usually can’t afford. “The question was, how do you fill that void for smaller not-for-profits?” said coowner and Vice President Dave Sternberg, former associate director of the Fundraising School at Indiana University’s Center on Philanthropy and…

Firm brings big-name help to small not-for-profits: Consultant will offer tiered Web-based advice to help keep its fees affordable

August 18, 2008

Huguenard a billion-dollar broker: Senior vice president at Colliers one of the nation’s top deal-makers

August 18, 2008

Turnaround may be in offing, observers say

August 14, 2008

Companies are quietly planning expansion projects despite woes that continue to unfold in housing, finance and other hard-hit industries, Indianapolis-area economic development officials say. The officials’ experiences differ, but a couple of them contacted in a spot check say requests for information from expansion-minded companies are becoming more common, and another says activity hasn’t fallen […]

Lilly taps hedge fund to cut research costs for Alzheimer’s drugs

August 11, 2008

Eli Lilly and Co.’s unorthodox efforts to develop new treatments for Alzheimer’s disease–if successful–could usher in
a new approach to drug development. The Indianapolis-based pharmaceutical company announced that a New York
hedge fund, TPG-Axon Capital, will invest up to $325 million to help cover the exorbitant development costs
of two experimental compounds to treat Alzheimer’s disease.

Push for personal medicine boosts firm: Software developer RND is busy working on gene-based diagnostic devices

August 11, 2008

The future of medicine is personal. That’s been the mantra of the pharmaceutical industry for the last decade-since the human genome was sequenced for the first time. But before Eli Lilly and Co. and its peers can develop and sell drugs that treat only patients with a specific gene, it needs sophisticated devices to test if a patient has that gene. And those devices need sophisticated software to make them run. That’s where The RND Group Inc. comes in. The…

« Previous 1 … 195 196 197 198 199 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

Expectations high as Economic Club opens season: Group sees turnaround in sponsorships, attendance

Lilly Endowment crawls toward diversification goal: Bear market, low Lilly stock price slow selloff

Commentary: Indiana law chases away talent

ON THE RECORD:

Zyprexa class action given green light

Lilly continues to build case for prasugrel

Elanco home base moving to life sciences park

Cymbalta helps lower-back pain, Lilly says

Citizens’ new name is a gas-in a way: Parent company of local utility adds ‘energy’ to its moniker to reflect diversity of operations

Cautious contractors warm to Lilly-Covance deal: Drugmaker works to assuage fears of some local researchers worried they might lose lucrative work

Lilly’s Cymbalta approved by European panel

Lilly buys dairy hormone unit for $300M

Lafayette officials hoping for best on Lilly plant

Huguenard a billion-dollar broker: Senior vice president at Colliers one of the nation’s top deal-makers

Firm brings big-name help to small not-for-profits: Consultant will offer tiered Web-based advice to help keep its fees affordable

Firm brings big-name help to small not-for-profits: Consultant will offer tiered Web-based advice to help keep its fees affordable

Huguenard a billion-dollar broker: Senior vice president at Colliers one of the nation’s top deal-makers

Turnaround may be in offing, observers say

Lilly taps hedge fund to cut research costs for Alzheimer’s drugs

Push for personal medicine boosts firm: Software developer RND is busy working on gene-based diagnostic devices